The Medicinal Species of the Lycium Genus (Goji Berries) in East Asia: A Review of Its Effect on Cell Signal Transduction Pathways.
Chenyu JiangZiyu ChenWeilin LiaoRen ZhangGeer ChenLijuan MaWilliam A CatterallPublished in: Plants (Basel, Switzerland) (2024)
Natural plants contain numerous chemical compounds that are beneficial to human health. The berries from the Lycium genus are widely consumed and are highly nutritious. Moreover, their chemical constituents have attracted attention for their health-promoting properties. In East Asia, there are three varieties of the Lycium genus ( Lycium barbarum L., Lycium chinense Miller , and L. ruthenicum Murray ) that possess medicinal value and are commonly used for treating chronic diseases and improving metabolic disorders. These varieties are locally referred to as "red Goji berries" or "black Goji berries" due to their distinct colors, and they differ in their chemical compositions, primarily in terms of carotenoid and anthocyanin content. The pharmacological functions of these berries include anti-aging, antioxidant, anti-inflammatory, and anti-exercise fatigue effects. This review aims to analyze previous and recent studies on the active ingredients and pharmacological activities of these Lycium varieties, elucidating their signaling pathways and assessing their impact on the gut microbiota. Furthermore, the potential prospects for using these active ingredients in the treatment of COVID-19 are evaluated. This review explores the potential targets of these Lycium varieties in the treatment of relevant diseases, highlighting their potential value in drug development.
Keyphrases
- human health
- risk assessment
- anti inflammatory
- climate change
- coronavirus disease
- public health
- sars cov
- healthcare
- signaling pathway
- single cell
- mental health
- physical activity
- working memory
- stem cells
- bone marrow
- mesenchymal stem cells
- epithelial mesenchymal transition
- endoplasmic reticulum stress
- respiratory syndrome coronavirus
- drug discovery